Gary L. Sender is on the board of Schrödinger, Inc. and 5 other companies. In his past career Mr. Sender occupied the position of CFO, Vice President-Finance & Administration at Tengion, Inc., Chief Financial Officer for Nabriva Therapeutics Plc and Chief Financial Officer of Nabriva Therapeutics GmbH (a subsidiary of Nabriva Therapeutics Plc), Senior Vice President-Finance for Shire Plc, Chief Financial Officer & Executive Vice President for Synergy Pharmaceuticals LLC and Head-Investor Relations & Treasury at Merck & Co.

Gary L. Sender received an undergraduate degree from Boston University and an MBA from Carnegie Mellon University.